BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37646771)

  • 1. The Search for a Reliable Biomarker in MEN1 Duodenopancreatic Neuroendocrine Tumors.
    Bulzico D
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1301-e1302. PubMed ID: 37646771
    [No Abstract]   [Full Text] [Related]  

  • 2. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.
    Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Murage E; Wu R; Dennison JB; Krishna H; Peterson CB; Lozano G; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Del Rivero J; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4969-e4980. PubMed ID: 34318891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
    Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
    Marini F; Giusti F; Tonelli F; Brandi ML
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic Patterns of Duodenopancreatic Neuroendocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1.
    Hackeng WM; van Beek DJ; Kok ASM; van Emst M; Morsink FHM; van Treijen MJC; Borel Rinkes IHM; Dreijerink KMA; Offerhaus GJA; Valk GD; Vriens MR; Brosens LAA
    Am J Surg Pathol; 2022 Feb; 46(2):159-168. PubMed ID: 34560682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
    Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG.
    Conemans EB; Nell S; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Vriens MR; Valk GD
    Endocr Pract; 2017 Jun; 23(6):641-648. PubMed ID: 28225311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
    Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
    Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple endocrine neoplasia type 1: about a case].
    Anguezomo G; El Mghari G; El Ansari N
    Pan Afr Med J; 2019; 33():238. PubMed ID: 31692695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
    Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
    Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
    Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
    Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study.
    Christou N; Mathonnet M; Gaujoux S; Cadiot G; Deguelte S; Kraimps JL; Lifante JC; Menegaux F; Mirallié E; Muscari F; Carnaille B; Pattou F; Sauvanet A; Goudet P
    World J Surg; 2019 Nov; 43(11):2856-2864. PubMed ID: 31384998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
    Komminoth P
    Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indication and Surgical Procedures for MEN1-associated Duodenopancreatic Neuroendocrine Neoplasms].
    Manoharan J; Albers M; Bartsch DK
    Zentralbl Chir; 2023 Dec; 148(6):483-491. PubMed ID: 37604166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future: medical advances in MEN1 therapeutic approaches and management strategies.
    van Leeuwaarde RS; de Laat JM; Pieterman CRC; Dreijerink K; Vriens MR; Valk GD
    Endocr Relat Cancer; 2017 Oct; 24(10):T179-T193. PubMed ID: 28768698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to treat gastrinomas in patients with multiple endocrine neoplasia type1: surgery or long-term proton pump inhibitors?
    Imamura M; Komoto I; Taki Y
    Surg Today; 2023 Dec; 53(12):1325-1334. PubMed ID: 36473964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.